Somatropin-containing medicines: monitoring
Following the review of somatropin-containing medicines, the European Medicines Agency confirms that their benefit / risk balance remains positive. Prescribers are reminded to adhere strictly to the indications and recommended doses. The somatropin-containing medicines marketed in Belgium are: Genotropin, Humatrope, Norditropin, Nutropin Aq, Omnitrope and Zomacton.
See the internet site of EMA.